Radboud University Medical Center
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
Real-time Imaging of Holmium Radioembolization: a Feasibility Study
Not Applicable
Completed
- Conditions
- Liver MetastasesLiver Cancer
- Interventions
- Device: QuiremSpheres®
- First Posted Date
- 2020-02-13
- Last Posted Date
- 2021-06-29
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 6
- Registration Number
- NCT04269499
- Locations
- 🇳🇱
Radboud University Medical Centre, Nijmegen, Gelderland, Netherlands
Long Term Complications in Head and Neck Cancer Patients
Not Applicable
- Conditions
- Head-and-neck Cancer
- Interventions
- Diagnostic Test: UltrasonographyDiagnostic Test: MRIDiagnostic Test: Neuro Psychological Assessment BatteryDiagnostic Test: Questionaires
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2020-02-06
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT04257968
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Netherlands
Low Pressure Pneumoperitoneum and Deep Neuromuscular Block vs. Standard During RARP to Improve Quality of Recovery; a Randomized Controlled Study.
Not Applicable
Completed
- Conditions
- Quality of LifePostoperative ComplicationsAcute PainImmune System Tolerance
- Interventions
- Other: Standard intra-abdominal pressureOther: Low intra-abdominal pressureOther: Moderate neuromuscular blockade (NMB)Other: Deep neuromuscular blockade (NMB)
- First Posted Date
- 2020-01-31
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 97
- Registration Number
- NCT04250883
- Locations
- 🇳🇱
Canisius Wilhelmina ziekenhuis, Nijmegen, Netherlands
F18-PSMA-1007 PET for Early Biochemical Recurrence of Prostate Cancer
Not Applicable
- Conditions
- Prostate Cancer Recurrent
- Interventions
- Diagnostic Test: F18-fluciclovine PET/CTDiagnostic Test: F18-PSMA-1007 PET/CT
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT04239742
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Netherlands
Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of TB31F
Phase 1
Completed
- Conditions
- Malaria,Falciparum
- Interventions
- Biological: TB31F
- First Posted Date
- 2020-01-23
- Last Posted Date
- 2023-03-27
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 25
- Registration Number
- NCT04238689
- Locations
- 🇳🇱
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands
Imaging of Tumour Microenvironment in Patients With Oropharyngeal Head and Neck Squamous Cell Carcinoma Using RGD PET/CT Imaging
Phase 2
- Conditions
- Oropharyngeal Squamous Cell Carcinoma
- Interventions
- Combination Product: RGD PET/CT
- First Posted Date
- 2020-01-10
- Last Posted Date
- 2020-01-10
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT04222543
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
DUAL Pathway Inhibition to Improve Endothelial Function in Peripheral Artery Disease
Phase 4
Completed
- Conditions
- Peripheral Artery Disease
- Interventions
- First Posted Date
- 2020-01-06
- Last Posted Date
- 2022-01-14
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 159
- Registration Number
- NCT04218656
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Netherlands
🇳🇱Rijnstate hospital, Arnhem, Netherlands
PSMA-PET Imaging Before and After ADT in Advanced SDC Patients
Not Applicable
- Conditions
- Salivary Duct CarcinomaSalivary Gland Cancer
- Interventions
- Diagnostic Test: 68Ga-PSMA-PET/CTDiagnostic Test: 18FDG-PET/CT
- First Posted Date
- 2020-01-02
- Last Posted Date
- 2022-08-16
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 14
- Registration Number
- NCT04214353
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients
Phase 2
Completed
- Conditions
- Endometrial Cancer
- Interventions
- Biological: Dendritic Cells for endometrial cancer
- First Posted Date
- 2019-12-27
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 8
- Registration Number
- NCT04212377
- Locations
- 🇳🇱
Radboud University Medical Center, Nijmegen, Netherlands
The Benefit of UHR-CT: Precision of Repeated Volume Measurements of Pulmonary Nodules
Not Applicable
Completed
- Conditions
- Pulmonary Nodule, Solitary
- Interventions
- Device: Genesis high-end CT scannerDevice: Precision Ultra-High-Resolution CT scanner
- First Posted Date
- 2019-12-24
- Last Posted Date
- 2019-12-24
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 92
- Registration Number
- NCT04209972
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
© Copyright 2025. All Rights Reserved by MedPath